Sale!

MT-TE Gene Mitochondrial Myopathy Infantile Transient NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MT-TE Gene Mitochondrial Myopathy Infantile Transient NGS Genetic DNA Test is a specialized genetic analysis that detects mutations in the MT-TE gene associated with infantile transient mitochondrial myopathy. This comprehensive test utilizes next-generation sequencing technology to identify specific genetic variations that cause mitochondrial dysfunction in infants. The test is crucial for early diagnosis of mitochondrial disorders characterized by muscle weakness, developmental delays, and transient symptoms in early childhood. By providing accurate genetic information, this test enables healthcare providers to develop targeted treatment strategies and provide appropriate genetic counseling for affected families. The test is priced at $500 USD and offers valuable insights into mitochondrial health and inherited conditions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MT-TE Gene Mitochondrial Myopathy Infantile Transient NGS Genetic DNA Test

Comprehensive Genetic Analysis for Mitochondrial Disorders

The MT-TE Gene Mitochondrial Myopathy Infantile Transient NGS Genetic DNA Test represents a cutting-edge diagnostic tool designed to identify mutations in the MT-TE gene, which plays a critical role in mitochondrial function and energy production within cells. Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondria—small, energy-producing structures that serve as the “powerhouses” of our cells. The infantile transient form specifically affects newborns and young children, often presenting with temporary symptoms that may resolve but can indicate underlying genetic conditions requiring medical attention.

What This Test Measures and Detects

This advanced genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the MT-TE gene for:

  • Point mutations and single nucleotide variants in mitochondrial DNA
  • Deletions and insertions affecting mitochondrial gene function
  • Pathogenic variants associated with infantile transient mitochondrial myopathy
  • Genetic markers indicating compromised mitochondrial energy production
  • Inheritance patterns of mitochondrial disorders

Who Should Consider This Test

This genetic test is recommended for infants and children exhibiting symptoms suggestive of mitochondrial dysfunction, including:

  • Unexplained muscle weakness or hypotonia (low muscle tone)
  • Developmental delays in motor skills or milestones
  • Transient episodes of weakness or fatigue that resolve spontaneously
  • Feeding difficulties or failure to thrive in infancy
  • Family history of mitochondrial disorders or unexplained infant illnesses
  • Episodic symptoms that come and go without clear explanation
  • Suspected metabolic disorders with fluctuating clinical presentation

Benefits of Genetic Testing

Undergoing the MT-TE Gene Mitochondrial Myopathy test provides numerous advantages for patients and families:

  • Early and Accurate Diagnosis: Enables precise identification of the underlying genetic cause of symptoms
  • Personalized Treatment Planning: Guides healthcare providers in developing targeted therapeutic approaches
  • Genetic Counseling Opportunities: Provides families with comprehensive information about inheritance patterns and recurrence risks
  • Improved Prognostic Understanding: Helps predict disease progression and potential outcomes
  • Family Planning Guidance: Assists in making informed decisions about future pregnancies
  • Reduced Diagnostic Odyssey: Minimizes unnecessary testing and medical procedures

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and specialists. Results typically fall into three categories:

  • Positive Result: Indicates the presence of a pathogenic mutation in the MT-TE gene, confirming the diagnosis of mitochondrial myopathy. This result provides clear direction for medical management and family counseling.
  • Negative Result: Suggests that no known pathogenic mutations were detected in the MT-TE gene. However, this does not completely rule out mitochondrial disorders, as other genetic or environmental factors may be involved.
  • Variant of Uncertain Significance (VUS): Identifies genetic changes whose clinical significance is currently unknown. Additional family testing or research may be recommended to clarify the finding.

Test Pricing Information

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have conveniently located testing facilities across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified collection centers ensures accessible genetic testing services for patients nationwide.

Take the Next Step Toward Genetic Clarity

If you suspect mitochondrial concerns in your child or have family history of similar conditions, don’t wait to get answers. Our comprehensive MT-TE Gene Mitochondrial Myopathy Infantile Transient NGS Genetic DNA Test provides the genetic insights needed for informed medical decisions and personalized care planning.

Book your test today by calling our genetic specialists at +1(267) 388-9828 or schedule your appointment online. Take control of your genetic health journey with confidence and clarity.